S Hiramoto, N Kinoshita, S Hatanaka, H Seto. Show Affiliations »
Abstract
Entities: Disease Gene Species
Mesh： See more » AnimalsApolipoproteins/drug effectsApolipoproteins/metabolismApolipoproteins E/drug effectsApolipoproteins E/metabolismBacillus/chemistryBacillus/metabolismCarcinoma, Hepatocellular/drug therapyCarcinoma, Hepatocellular/metabolismCarcinoma, Hepatocellular/pathologyCholesterol/bloodHumansHypolipidemic Agents/chemistryHypolipidemic Agents/pharmacologyMaleMolecular StructurePeptides, Cyclic/chemistryPeptides, Cyclic/metabolismPeptides, Cyclic/pharmacologyProtein Synthesis Inhibitors/chemistryProtein Synthesis Inhibitors/pharmacologyRatsRats, Sprague-DawleySpectrometry, Mass, Fast Atom BombardmentTumor Cells, Cultured
Substances： See more » 3-hydroxy-13-methyltetradecanoic acidApolipoproteinsApolipoproteins EHypolipidemic AgentsPeptides, CyclicProtein Synthesis InhibitorsisohalobacillinCholesterol
Year: 1996 PMID： 8931734 DOI： 10.7164/antibiotics.49.949
Source DB: PubMed Journal: J Antibiot (Tokyo) ISSN： 0021-8820 Impact factor: 2.649